Like

DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low

After reviewing the FDA's information requests and considering all other options, DBV Technologies h
DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论2

  • 推荐
  • 最新
empty
暂无评论